US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Why Analysts See a Potential 64% Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is drawing investor attention with its intriguing blend of innovative therapies for rare diseases and a compelling market position in the..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: Navigating a 15.75% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Smith & Nephew SNATS, Inc. (NYSE: SNN) presents an intriguing prospect. With a market capitalization of $13.43 billion,..

Boston Scientific Corporation (BSX)

⚠️ No article content returned.

..

BridgeBio Pharma (BBIO) Stock Analysis: A Potential 44% Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector, not only for its innovative approach to treating genetic diseases but also for its impressive..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Look Into Its High Growth Potential and Strong Investor Interest

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a compelling player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Riding the Wave of RAS-Innovative Oncology with 44% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is making waves in the healthcare sector with its cutting-edge approach to targeting RAS-addicted cancers. With a..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Challenges and Opportunities in the TCM Sector

Regencell Bioscience Holdings Limited (RGC), a prominent player in the healthcare sector, stands at the crossroads of opportunity and challenge. This Hong Kong-based company operates at..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Reveals 34% Upside Potential Amid Robust Pipeline

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is capturing investor attention with its RNA-targeted medicines and a promising array of products..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with a 42% Potential Upside

Revvity, Inc. (NASDAQ: RVTY), a prominent player in the healthcare sector, stands out as a compelling investment opportunity. With its roots firmly planted in the United..

Qiagen N.V. (QGEN) Stock Analysis: Unlocking a 41.96% Potential Upside in the Diagnostics & Research Sector

Qiagen N.V. (NASDAQ: QGEN) stands as a prominent player in the healthcare sector, specifically within diagnostics and research. Headquartered in Venlo, Netherlands, Qiagen is renowned for..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth in a Volatile Market

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable entity in the healthcare sector, particularly within the general drug manufacturing industry. With a substantial market capitalization..

Merck & Company, Inc. (MRK) Stock Analysis: 7.03% Potential Upside Sparks Investor Interest

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, particularly within the general drug manufacturing industry, has long been a favorite among investors..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 48.20% Upside for Investors

For individual investors eyeing opportunities in the healthcare sector, Grifols, S.A. (NASDAQ: GRFS) presents a compelling case. Based in Barcelona, Spain, this global leader in plasma-derived..

Merit Medical Systems (MMSI) Stock Analysis: A 48% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With its strong market presence and innovative..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Viatris Inc. (VTRS) Investor Outlook: Analyzing a 20.48% Potential Upside Amidst Industry Dynamics

Viatris Inc. (NASDAQ: VTRS) presents a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With..

Repligen Corporation (RGEN) Stock Analysis: Unveiling a 69.65% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.62% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the specialty and generic drug manufacturing sector, offers a unique investment opportunity amidst a backdrop of..

The Cigna Group (CI) Stock Analysis: Unveiling a 29.33% Upside Potential Amid Robust Revenue Growth

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, has been drawing significant attention from investors with its substantial 29.33% potential upside, according to..

Globus Medical, Inc. (GMED) Stock Analysis: Unpacking the 31.40% Potential Upside

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, particularly within the medical devices industry, with its focus on innovative solutions for musculoskeletal disorders...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds